Bicocca Open Archive

Logo unimib boa
CADAMURO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.704
AS - Asia 8.548
EU - Europa 5.057
SA - Sud America 1.171
AF - Africa 206
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 13
Totale 25.720
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.107
SG - Singapore 2.690
CN - Cina 1.838
VN - Vietnam 1.478
IT - Italia 1.110
HK - Hong Kong 1.056
RU - Federazione Russa 974
BR - Brasile 884
SE - Svezia 596
DE - Germania 558
CA - Canada 491
IE - Irlanda 450
GB - Regno Unito 285
UA - Ucraina 283
BD - Bangladesh 246
IN - India 238
FR - Francia 221
KR - Corea 220
FI - Finlandia 198
ID - Indonesia 142
AR - Argentina 115
IQ - Iraq 102
TR - Turchia 101
JP - Giappone 86
ES - Italia 73
ZA - Sudafrica 71
PK - Pakistan 70
MX - Messico 65
NL - Olanda 61
AT - Austria 51
EC - Ecuador 46
PL - Polonia 45
CO - Colombia 41
UZ - Uzbekistan 37
SA - Arabia Saudita 36
DK - Danimarca 30
TW - Taiwan 28
MA - Marocco 27
VE - Venezuela 27
PH - Filippine 25
BE - Belgio 21
EG - Egitto 20
CL - Cile 18
KE - Kenya 18
CH - Svizzera 17
JO - Giordania 17
PY - Paraguay 16
AU - Australia 15
TH - Thailandia 15
TN - Tunisia 15
MY - Malesia 14
CZ - Repubblica Ceca 13
IL - Israele 13
DZ - Algeria 12
ET - Etiopia 12
EU - Europa 12
LT - Lituania 12
NO - Norvegia 11
NP - Nepal 11
IR - Iran 10
AE - Emirati Arabi Uniti 9
LB - Libano 9
PS - Palestinian Territory 9
AL - Albania 8
PE - Perù 8
RO - Romania 8
UY - Uruguay 8
BO - Bolivia 7
CR - Costa Rica 7
JM - Giamaica 7
BH - Bahrain 6
HN - Honduras 6
KG - Kirghizistan 6
KZ - Kazakistan 6
RS - Serbia 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
NG - Nigeria 5
AO - Angola 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
BG - Bulgaria 3
GA - Gabon 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
MD - Moldavia 3
MN - Mongolia 3
PT - Portogallo 3
QA - Qatar 3
SY - Repubblica araba siriana 3
AM - Armenia 2
HU - Ungheria 2
LY - Libia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 25.692
Salva come PNG Salva come JPEG
Città #
Singapore 1.603
Hong Kong 998
Ann Arbor 991
Ashburn 909
San Jose 705
Fairfield 569
Woodbridge 546
Ho Chi Minh City 482
Chandler 458
Houston 454
Dublin 435
New York 359
Hanoi 354
Toronto 345
Hefei 321
Frankfurt am Main 320
Wilmington 281
Jacksonville 274
Milan 266
Beijing 262
Seattle 255
Los Angeles 245
Santa Clara 239
Dallas 230
Dearborn 224
Chicago 198
The Dalles 192
Seoul 188
Cambridge 181
Princeton 145
Council Bluffs 131
Lauterbourg 123
Helsinki 111
Nanjing 107
Buffalo 102
Jakarta 98
Shanghai 90
São Paulo 83
Moscow 78
Boardman 74
Guangzhou 67
Lawrence 55
Munich 55
Tokyo 54
Da Nang 52
Orem 52
Rome 50
Hangzhou 47
Lachine 46
Baghdad 44
Chennai 42
Haiphong 40
Montreal 39
Altamura 37
London 36
Brooklyn 34
Nuremberg 33
Shenyang 33
San Diego 32
Tashkent 32
Atlanta 31
Warsaw 30
Andover 27
Ha Long 26
Salt Lake City 26
Vienna 26
Zhengzhou 26
Can Tho 25
Changsha 25
Johannesburg 25
Rio de Janeiro 25
Brasília 24
Dhaka 23
Lappeenranta 23
Nanchang 23
Padova 23
Thái Nguyên 23
Denver 22
Hải Dương 22
Biên Hòa 21
Fremont 21
Lahore 21
Ottawa 21
Pune 21
Tianjin 21
Brussels 20
Kunming 19
Manchester 19
Mexico City 18
Columbus 17
Hebei 17
Phoenix 17
Amman 16
Ankara 16
Belo Horizonte 16
Bắc Giang 16
Istanbul 16
Jinan 16
Nairobi 16
New Delhi 16
Totale 15.762
Salva come PNG Salva come JPEG
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 672
Innovative and Efficient Oral Delivery Method of APOA-1Milano Muteins Which Retain Anti-Atherosclerotic and Anti-Inflammatory Properties 529
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe −/− atherosclerotic mice 489
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTATIZATION IN CHOLANGIOCARCINOMA 429
Nephrosphere-Derived Cells are Induced to Multilineage Differentiation when Cultured on Human Decellularized Kidney Scaffolds 413
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 385
Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models 345
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 334
A ploidy increase promotes sensitivity of glioma stem cells to aurora kinases inhibition 320
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 314
The tumor microenvironment in hepatocarcinoma: dissecting the functions of cancer-associated fibroblasts 310
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 310
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 298
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 287
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 287
Cholangiocyte biology as relevant to cystic liver diseases 278
Signaling and molecular networks related to development and inflammation involved in CCA initiation and progression 274
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 270
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 269
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 267
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 264
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 262
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 260
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 255
Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19 251
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 250
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 250
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 249
Animal models of cholestasis: An update on inflammatory cholangiopathies 248
Neural stem/progenitor cells from olfactory neuroepithelium collected by nasal brushing as a cell model reflecting molecular and cellular dysfunctions in schizophrenia 245
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 244
JNK SIGNALING ACTIVATED BY PLATELET-DERIVED GROWTH FACTOR D (PDGF-D) STIMULATES SECRETION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-C (VEGF-C) BY CANCER-ASSOCIATED FIBROBLASTS TO PROMOTE LYMPHANGIOGENESIS AND EARLY METASTASIZATION IN CHOLANGIOCARCINOMA 243
Pka-dependent p-ser-675-catenin phosphorylation increases cholangiocyte motility in a mouse model of fibropolycystic liver diseases 243
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 242
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 238
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 236
Notch signaling and progenitor/ductular reaction in steatohepatitis 234
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 233
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 229
The Deleterious Interplay Between Tumor Epithelia and Stroma in Cholangiocarcinoma 229
TIMP1 Overexpression in Ovarian Cancer Spheroids: Implications for Prognosis, Resistance, and Metastatic Potential 226
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 226
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 218
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 218
Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions 214
Protein kinase a-dependent pSer(675) -β-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis 213
Autocrine and paracrine mechanisms promoting chemoresistance in cholangiocarcinoma 213
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 212
Emerging concepts in biliary repair and fibrosis 212
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 209
The patient presenting with isolated hyperbilirubinemia 209
FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob/ob mouse model of NASH 200
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM. 197
Cxcl1 and cxcl10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 197
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation 197
Cholangiocarcinoma 196
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 193
Animal models for cystic fibrosis liver disease (CFLD) 193
Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression 192
CXCL1 and CXCL10 secretion by fibrocistidefective cholangiocytes recruits peribiliary fibrocytes in congenital hepatic fibrosis 192
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 189
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C 187
Role of angiogenesis and angiogenic factors for cholangiocyte growth 185
Fibroinflammatory liver injuries as preneoplastic condition in cholangiopathies 185
Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1−/− mouse model of congenital hepatic fibrosis 182
Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis 182
Gender differences in repair mechanisms of chronic cholangiopathies with progressive fibrosis 182
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance 179
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 179
Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma: Insights into Origins, Heterogeneity, Lymphangiogenesis, and Peritoneal Metastasis 178
The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored 177
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma 175
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease 173
SELECTIVE REDUCTION IN S100A4 NUCLEAR EXPRESSION BY LOW-DOSE PACLITAXEL HALTS INVASIVENESS OF HUMAN CHOLANGIOCARCINOMA CELLS THROUGH A RAC1-INDEPENDENT, RHO-A/CDC42-DEPENDENT MECHANISM 173
Animal models of cholangiocarcinoma: What they teach us about the human disease 173
Cirrosi Biliare Primitiva 172
Intrahepatic cholangiocarcinoma developing in patients with metabolic syndrome is characterized by Osteopontin overexpression in the tumor stroma 170
The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit 170
Leukaemia Inhibitory Factor Protects Cholangiocarcinoma Cells From Cytotoxicity Via MCL-1 169
Tumor microenvironment and immunology of cholangiocarcinoma 168
The healthy biliary tree: Cellular and immune biology 168
Cholangiocarcinoma 165
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer 164
Advanced endoscopy meets molecular diagnosis of cholangiocarcinoma 163
β-catenin and IL-1β dependent CXCL10 production drives progression of disease in a mouse model of Congenital Hepatic Fibrosis 163
Molecular pathology analysis of sars-cov-2 in syncytiotrophoblast and hofbauer cells in placenta from a pregnant woman and fetus with covid-19 161
The multitasking behavior of cholangiocyte in the reaction to liver damage 160
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases 160
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 157
Evidence of vertical transmission of SARS-CoV-2 and interstitial pneumonia in second-trimester twin stillbirth in asymptomatic woman. Case report and review of the literature 156
Colestasi intraepatica 152
Colangite Sclerosante Primitiva 149
Secretion of Vascular Endothelial Growth Factor-C by Cancer-Associated Fibroblasts (CAF) Is Stimulated by Platelet-Derived Growth Factor D (PDGF-D) and Promotes Lymphangiogenesis in Cholangiocarcinoma 148
Leukaemia inhibitory factor protects cholangiocytes from cytotoxicity in cholangiocarcinoma 148
Oxidative Stress in Non-Autoimmune Liver Diseases 148
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 146
Colestasi Genetiche 145
Anti-Inflammatory and Pro-Regenerative Effects of Hyaluronan-Chitlac Mixture in Human Dermal Fibroblasts: A Skin Ageing Perspective 144
RAC1 and CDC42 activation regulates pdgf‐d mediated caf recruitment by cancer cells in cholangiocarcinoma 142
Inhibition of YAP activation induces cell senescence and autophagy while blocking cell proliferation in cholangiocarcinoma (CCA) 136
Totale 22.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 0 0 67
2021/2022722 52 69 92 45 27 50 31 37 36 67 85 131
2022/20231.670 167 501 166 161 118 240 26 89 100 12 45 45
2023/20242.104 76 70 68 131 351 467 355 103 223 19 39 202
2024/20254.715 275 532 334 175 388 221 229 203 366 706 504 782
2025/202611.608 1.605 1.103 781 1.188 1.158 598 1.523 534 888 1.116 831 283
Totale 26.317